
Stenride M 1mg/500mg Tablet SR
Marketer
Alvoncare Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Stenride M 1mg/500mg Tablet SR
Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled glucose levels; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse effect of Diabexe Duo is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and always carry a readily available fast-acting carbohydrate source, such as glucose tablets or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility for some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment, as it may be unsuitable. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function as deemed necessary by your doctor.
Primary Ingredients of Stenride M 1mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Stenride M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Stenride M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Stenride M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Stenride M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Stenride M 1mg/500mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Stenride M 1mg/500mg Extended-Release tablets with food.
How Stenride M 1mg/500mg Tablet SR works:
Stenride M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Stenride M 1mg/500mg Tablet SR is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Stenride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Stenride M (1mg/500mg) tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Stenride M 1mg/500mg SR tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Stenride M 1mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Stenride M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, a low initial dose is typically prescribed; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Stenride M 1mg/500mg Tablet SR :
Should you forget to take a Stenride M 1mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Stenride M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
